-
1 Comment
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd is currently in a long term uptrend where the price is trading 39.2% above its 200 day moving average.
From a valuation standpoint, the stock is 380.7% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 46.3.
Based on the above factors, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd gets an overall score of 1/5.
| ISIN | CNE100004090 |
|---|---|
| CurrencyCode | CNY |
| Exchange | SHG |
| Industry | Biotechnology |
| Sector | Healthcare |
| Beta | 1.39 |
|---|---|
| Market Cap | 58B |
| PE Ratio | None |
| Target Price | 61.4 |
| Dividend Yield | None |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells in vitro diagnostic reagents and instruments, and vaccines in China and internationally. It operates through Diagnostics Division and Vaccine Division segments. The company offers chemiluminescence detection, biochemical, hepatitis B core antibody detection, and HIV reagents; rapid urine tests for hepatitis E antigen; chronic disease management, hepatitis E screening and prevention, women's full life-cycle health management, smart laboratories, medical laboratory quality and competence accreditation, lean management consulting, blood safety testing, and internal quality control solutions; enzyme-linked immunosorbent assay, colloidal gold, nucleic acid, clinical test quality control products, and raw materials; and nucleic acid testing devices. It also provides HPV, hepatitis E, and nasal spray COVID-19 vaccines. In addition, the company offers bio-immune and immunoassay instruments, as well as automated production lines. Further, it provides bio-immune assays, including hepatitis virus, P85-Ab, TB-IGRA, and biochemical gastric tests; biochemical assays comprising helicobacter pylori antibodies, gastrin 17, and soluble transferrin receptors; and support services, such as after-sales and training center services. Additionally, the company engages in technology business incubation and development activities. The company was founded in 1991 and is headquartered in Beijing, China. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a subsidiary of Yangshengtang Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603392.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
